Clinical relevance of inflammatory markers in the evaluation of severity of ulcerative colitis: A retrospective study
This study aimed to investigate the clinical relevance of inflammatory markers in the severity assessment of ulcerative colitis (UC). The inflammatory markers included the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), C-reactive protein (CRP), erythrocyte sedimentation ra...
Saved in:
Published in | Open life sciences Vol. 20; no. 1; pp. 20251088 - 6 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Poland
De Gruyter
05.05.2025
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | This study aimed to investigate the clinical relevance of inflammatory markers in the severity assessment of ulcerative colitis (UC). The inflammatory markers included the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and calcium ion (Ca
) levels. A retrospective analysis was on 110 patients with UC and 52 patients with irritable bowel syndrome (IBS), admitted to Weifang People’s Hospital between June 2019 and February 2021. UC severity was classified using the modified Mayo score and the Montreal classification system. The study assessed the predictive accuracy and correlation of these inflammatory markers with UC severity and extent. Levels of NLR, PLR, CRP, ESR, and Ca
were significantly elevated in individuals with UC compared to those with IBS. Among patients with UC, significant differences in these markers were observed across varying severity levels as defined by the modified Mayo score. However, aside from ESR, no significant differences were noted in NLR, PLR, CRP, or Ca
levels across groups defined by lesion extent. Receiver operating characteristic curve analysis indicated that NLR exhibited the highest predictive accuracy for UC, with a cut-off value of 2.603 yielding a sensitivity of 0.545, specificity of 0.288, and an area under the curve (AUC) of 0.896. The combined use of NLR, PLR, CRP, ESR, and Ca
demonstrated superior predictive performance, achieving an AUC of 0.972, sensitivity of 0.927, and specificity of 0.923 at a cut-off value of 0.455. NLR, PLR, CRP, ESR, and Ca
exhibit predictive value for UC, with NLR demonstrating the highest individual predictive performance. The combined use of these markers enhances predictive accuracy, highlighting their potential application in clinical practice for the evaluation of severity UC. Due to ethical considerations at our institution, the IBS group was used as a substitute for healthy controls. The IBS group was included solely for the calibration and testing of inflammatory biomarkers, as well as for subsequent analysis of their role in assessing UC severity. |
---|---|
AbstractList | This study aimed to investigate the clinical relevance of inflammatory markers in the severity assessment of ulcerative colitis (UC). The inflammatory markers included the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and calcium ion (Ca
) levels. A retrospective analysis was on 110 patients with UC and 52 patients with irritable bowel syndrome (IBS), admitted to Weifang People’s Hospital between June 2019 and February 2021. UC severity was classified using the modified Mayo score and the Montreal classification system. The study assessed the predictive accuracy and correlation of these inflammatory markers with UC severity and extent. Levels of NLR, PLR, CRP, ESR, and Ca
were significantly elevated in individuals with UC compared to those with IBS. Among patients with UC, significant differences in these markers were observed across varying severity levels as defined by the modified Mayo score. However, aside from ESR, no significant differences were noted in NLR, PLR, CRP, or Ca
levels across groups defined by lesion extent. Receiver operating characteristic curve analysis indicated that NLR exhibited the highest predictive accuracy for UC, with a cut-off value of 2.603 yielding a sensitivity of 0.545, specificity of 0.288, and an area under the curve (AUC) of 0.896. The combined use of NLR, PLR, CRP, ESR, and Ca
demonstrated superior predictive performance, achieving an AUC of 0.972, sensitivity of 0.927, and specificity of 0.923 at a cut-off value of 0.455. NLR, PLR, CRP, ESR, and Ca
exhibit predictive value for UC, with NLR demonstrating the highest individual predictive performance. The combined use of these markers enhances predictive accuracy, highlighting their potential application in clinical practice for the evaluation of severity UC. Due to ethical considerations at our institution, the IBS group was used as a substitute for healthy controls. The IBS group was included solely for the calibration and testing of inflammatory biomarkers, as well as for subsequent analysis of their role in assessing UC severity. This study aimed to investigate the clinical relevance of inflammatory markers in the severity assessment of ulcerative colitis (UC). The inflammatory markers included the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and calcium ion (Ca 2+ ) levels. A retrospective analysis was on 110 patients with UC and 52 patients with irritable bowel syndrome (IBS), admitted to Weifang People’s Hospital between June 2019 and February 2021. UC severity was classified using the modified Mayo score and the Montreal classification system. The study assessed the predictive accuracy and correlation of these inflammatory markers with UC severity and extent. Levels of NLR, PLR, CRP, ESR, and Ca 2+ were significantly elevated in individuals with UC compared to those with IBS. Among patients with UC, significant differences in these markers were observed across varying severity levels as defined by the modified Mayo score. However, aside from ESR, no significant differences were noted in NLR, PLR, CRP, or Ca 2+ levels across groups defined by lesion extent. Receiver operating characteristic curve analysis indicated that NLR exhibited the highest predictive accuracy for UC, with a cut-off value of 2.603 yielding a sensitivity of 0.545, specificity of 0.288, and an area under the curve (AUC) of 0.896. The combined use of NLR, PLR, CRP, ESR, and Ca 2+ demonstrated superior predictive performance, achieving an AUC of 0.972, sensitivity of 0.927, and specificity of 0.923 at a cut-off value of 0.455. NLR, PLR, CRP, ESR, and Ca 2+ exhibit predictive value for UC, with NLR demonstrating the highest individual predictive performance. The combined use of these markers enhances predictive accuracy, highlighting their potential application in clinical practice for the evaluation of severity UC. Due to ethical considerations at our institution, the IBS group was used as a substitute for healthy controls. The IBS group was included solely for the calibration and testing of inflammatory biomarkers, as well as for subsequent analysis of their role in assessing UC severity. This study aimed to investigate the clinical relevance of inflammatory markers in the severity assessment of ulcerative colitis (UC). The inflammatory markers included the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and calcium ion (Ca 2+ ) levels. A retrospective analysis was on 110 patients with UC and 52 patients with irritable bowel syndrome (IBS), admitted to Weifang People’s Hospital between June 2019 and February 2021. UC severity was classified using the modified Mayo score and the Montreal classification system. The study assessed the predictive accuracy and correlation of these inflammatory markers with UC severity and extent. Levels of NLR, PLR, CRP, ESR, and Ca 2+ were significantly elevated in individuals with UC compared to those with IBS. Among patients with UC, significant differences in these markers were observed across varying severity levels as defined by the modified Mayo score. However, aside from ESR, no significant differences were noted in NLR, PLR, CRP, or Ca 2+ levels across groups defined by lesion extent. Receiver operating characteristic curve analysis indicated that NLR exhibited the highest predictive accuracy for UC, with a cut-off value of 2.603 yielding a sensitivity of 0.545, specificity of 0.288, and an area under the curve (AUC) of 0.896. The combined use of NLR, PLR, CRP, ESR, and Ca 2+ demonstrated superior predictive performance, achieving an AUC of 0.972, sensitivity of 0.927, and specificity of 0.923 at a cut-off value of 0.455. NLR, PLR, CRP, ESR, and Ca 2+ exhibit predictive value for UC, with NLR demonstrating the highest individual predictive performance. The combined use of these markers enhances predictive accuracy, highlighting their potential application in clinical practice for the evaluation of severity UC. Due to ethical considerations at our institution, the IBS group was used as a substitute for healthy controls. The IBS group was included solely for the calibration and testing of inflammatory biomarkers, as well as for subsequent analysis of their role in assessing UC severity. This study aimed to investigate the clinical relevance of inflammatory markers in the severity assessment of ulcerative colitis (UC). The inflammatory markers included the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and calcium ion (Ca2+) levels. A retrospective analysis was on 110 patients with UC and 52 patients with irritable bowel syndrome (IBS), admitted to Weifang People’s Hospital between June 2019 and February 2021. UC severity was classified using the modified Mayo score and the Montreal classification system. The study assessed the predictive accuracy and correlation of these inflammatory markers with UC severity and extent. Levels of NLR, PLR, CRP, ESR, and Ca2+ were significantly elevated in individuals with UC compared to those with IBS. Among patients with UC, significant differences in these markers were observed across varying severity levels as defined by the modified Mayo score. However, aside from ESR, no significant differences were noted in NLR, PLR, CRP, or Ca2+ levels across groups defined by lesion extent. Receiver operating characteristic curve analysis indicated that NLR exhibited the highest predictive accuracy for UC, with a cut-off value of 2.603 yielding a sensitivity of 0.545, specificity of 0.288, and an area under the curve (AUC) of 0.896. The combined use of NLR, PLR, CRP, ESR, and Ca2+ demonstrated superior predictive performance, achieving an AUC of 0.972, sensitivity of 0.927, and specificity of 0.923 at a cut-off value of 0.455. NLR, PLR, CRP, ESR, and Ca2+ exhibit predictive value for UC, with NLR demonstrating the highest individual predictive performance. The combined use of these markers enhances predictive accuracy, highlighting their potential application in clinical practice for the evaluation of severity UC. Due to ethical considerations at our institution, the IBS group was used as a substitute for healthy controls. The IBS group was included solely for the calibration and testing of inflammatory biomarkers, as well as for subsequent analysis of their role in assessing UC severity. This study aimed to investigate the clinical relevance of inflammatory markers in the severity assessment of ulcerative colitis (UC). The inflammatory markers included the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and calcium ion (Ca2+) levels. A retrospective analysis was on 110 patients with UC and 52 patients with irritable bowel syndrome (IBS), admitted to Weifang People's Hospital between June 2019 and February 2021. UC severity was classified using the modified Mayo score and the Montreal classification system. The study assessed the predictive accuracy and correlation of these inflammatory markers with UC severity and extent. Levels of NLR, PLR, CRP, ESR, and Ca2+ were significantly elevated in individuals with UC compared to those with IBS. Among patients with UC, significant differences in these markers were observed across varying severity levels as defined by the modified Mayo score. However, aside from ESR, no significant differences were noted in NLR, PLR, CRP, or Ca2+ levels across groups defined by lesion extent. Receiver operating characteristic curve analysis indicated that NLR exhibited the highest predictive accuracy for UC, with a cut-off value of 2.603 yielding a sensitivity of 0.545, specificity of 0.288, and an area under the curve (AUC) of 0.896. The combined use of NLR, PLR, CRP, ESR, and Ca2+ demonstrated superior predictive performance, achieving an AUC of 0.972, sensitivity of 0.927, and specificity of 0.923 at a cut-off value of 0.455. NLR, PLR, CRP, ESR, and Ca2+ exhibit predictive value for UC, with NLR demonstrating the highest individual predictive performance. The combined use of these markers enhances predictive accuracy, highlighting their potential application in clinical practice for the evaluation of severity UC. Due to ethical considerations at our institution, the IBS group was used as a substitute for healthy controls. The IBS group was included solely for the calibration and testing of inflammatory biomarkers, as well as for subsequent analysis of their role in assessing UC severity.This study aimed to investigate the clinical relevance of inflammatory markers in the severity assessment of ulcerative colitis (UC). The inflammatory markers included the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and calcium ion (Ca2+) levels. A retrospective analysis was on 110 patients with UC and 52 patients with irritable bowel syndrome (IBS), admitted to Weifang People's Hospital between June 2019 and February 2021. UC severity was classified using the modified Mayo score and the Montreal classification system. The study assessed the predictive accuracy and correlation of these inflammatory markers with UC severity and extent. Levels of NLR, PLR, CRP, ESR, and Ca2+ were significantly elevated in individuals with UC compared to those with IBS. Among patients with UC, significant differences in these markers were observed across varying severity levels as defined by the modified Mayo score. However, aside from ESR, no significant differences were noted in NLR, PLR, CRP, or Ca2+ levels across groups defined by lesion extent. Receiver operating characteristic curve analysis indicated that NLR exhibited the highest predictive accuracy for UC, with a cut-off value of 2.603 yielding a sensitivity of 0.545, specificity of 0.288, and an area under the curve (AUC) of 0.896. The combined use of NLR, PLR, CRP, ESR, and Ca2+ demonstrated superior predictive performance, achieving an AUC of 0.972, sensitivity of 0.927, and specificity of 0.923 at a cut-off value of 0.455. NLR, PLR, CRP, ESR, and Ca2+ exhibit predictive value for UC, with NLR demonstrating the highest individual predictive performance. The combined use of these markers enhances predictive accuracy, highlighting their potential application in clinical practice for the evaluation of severity UC. Due to ethical considerations at our institution, the IBS group was used as a substitute for healthy controls. The IBS group was included solely for the calibration and testing of inflammatory biomarkers, as well as for subsequent analysis of their role in assessing UC severity. |
Author | Qiu, Shi-Lin He, Tao Liu, Mei-Qin Sun, Shan-Ming Song, Lian-Qiang Weng, Xiao-Yu Pan, Peng Ding, Hui |
Author_xml | – sequence: 1 givenname: Tao surname: He fullname: He, Tao organization: Department of Gastroenterology, Weifang People’s Hospital, Shandong Second Medical University, No. 151 of Guangwen Road, Kuiwen District, Weifang, 261000, China – sequence: 2 givenname: Lian-Qiang surname: Song fullname: Song, Lian-Qiang organization: Department of Gastroenterology, Weifang People’s Hospital, Shandong Second Medical University, No. 151 of Guangwen Road, Kuiwen District, Weifang, 261000, China – sequence: 3 givenname: Xiao-Yu surname: Weng fullname: Weng, Xiao-Yu organization: Department of Gastroenterology, Weifang People’s Hospital, Shandong Second Medical University, No. 151 of Guangwen Road, Kuiwen District, Weifang, 261000, China – sequence: 4 givenname: Peng surname: Pan fullname: Pan, Peng organization: Department of Gastroenterology, Weifang People’s Hospital, Shandong Second Medical University, No. 151 of Guangwen Road, Kuiwen District, Weifang, 261000, China – sequence: 5 givenname: Hui surname: Ding fullname: Ding, Hui organization: Department of Gastroenterology, Weifang People’s Hospital, Shandong Second Medical University, No. 151 of Guangwen Road, Kuiwen District, Weifang, 261000, China – sequence: 6 givenname: Mei-Qin surname: Liu fullname: Liu, Mei-Qin organization: Department of Endocrinology, Weifang Respiratory Disease Hospital, Shandong Second Medical University, Weifang, 261000, China – sequence: 7 givenname: Shi-Lin surname: Qiu fullname: Qiu, Shi-Lin email: shilinshineslq@126.com organization: Department of Gastroenterology, Weifang People’s Hospital, Shandong Second Medical University, No. 151 of Guangwen Road, Kuiwen District, Weifang, 261000, China – sequence: 8 givenname: Shan-Ming surname: Sun fullname: Sun, Shan-Ming email: sunshanming2023@163.com organization: Department of Gastroenterology, Weifang People’s Hospital, Shandong Second Medical University, No. 151 of Guangwen Road, Kuiwen District, Weifang, 261000, China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40356724$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kkFv1DAQhSNUREvplSPKkUta27GdmAuqVkArVeICZ8uxx1svTrzYzqL8e5xuqdoDJ49m3nwjz7y31ckUJqiq9xhdYobZ1eCCbwgirMGo719VZ6QVuGEUk5Nn8Wl1kdIOIYQZJQzxN9UpRS3jHaFn1bzxbnJa-TqCh4OaNNTB1m6yXo2jyiEu9ajiL4ipJOt8D3VR-VllF6ZVmeAA0eVljWevIZbKAWodvMsufaqvCzjHkPagHwopz2Z5V722yie4eHzPq59fv_zY3DR337_dbq7vGk05zY3pe6rE0BNG-CA6YyjTHeuo5YIJqgbbM6E1NaI33HbdMHDNOmLADrwXhLfteXV75JqgdnIfXfnKIoNy8iER4laqmJ32ILHttEZgbKvLmrhVZkDQaTEwLFiru8L6fGTt52EEo2HKUfkX0JeVyd3LbThITBDvcc8K4eMjIYbfM6QsR5c0eK8mCHOSLUFti6gQokg_PB_2NOXf4Yrg8ijQZbcpgn2SYCRXc8jVHHI1h1zNURrEseGP8hmigW2clxLIXZjjVI7wn0aCcPsXa33C9Q |
Cites_doi | 10.1136/gut.2005.082909 10.1080/07853890.2024.2398725 10.3390/nu13082583 10.1016/j.intimp.2021.108235 10.1016/S0140-6736(17)32448-0 10.1053/j.gastro.2006.12.038 10.1089/ars.2012.4530 10.1053/j.gastro.2016.02.032 10.1152/ajpgi.00455.2015 10.1097/CM9.0000000000003221 10.5217/ir.2019.09156 10.1016/B978-0-12-824472-2.00011-7 10.1097/MS9.0000000000001297 10.5009/gnl17216 10.3390/cancers16162911 10.3390/jcm5120118 10.2478/fzm-2024-0003 10.1515/jomb-2017-0050 10.1016/j.molmed.2008.09.006 10.1093/ecco-jcc/jjy215 10.3390/ijms25137062 10.1186/s43046-024-00208-4 10.1038/ajg.2015.6 |
ContentType | Journal Article |
Copyright | 2025 the author(s), published by De Gruyter. 2025 the author(s), published by De Gruyter 2025 the author(s), published by De Gruyter |
Copyright_xml | – notice: 2025 the author(s), published by De Gruyter. – notice: 2025 the author(s), published by De Gruyter 2025 the author(s), published by De Gruyter |
DBID | AAYXX CITATION NPM 7X8 5PM DOA |
DOI | 10.1515/biol-2025-1088 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | CrossRef PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 2391-5412 |
EndPage | 6 |
ExternalDocumentID | oai_doaj_org_article_1f7cc0edf3c5426fadb0e7c9b51953c7 PMC12068185 40356724 10_1515_biol_2025_1088 10_1515_biol_2025_1088201 |
Genre | Journal Article |
GroupedDBID | 5VS AAFWJ ABFKT ACGFS ADBBV AENEX AFBDD AFPKN AHGSO ALMA_UNASSIGNED_HOLDINGS BCNDV EBS ECGQY GROUPED_DOAJ KQ8 M~E PGMZT QD8 RPM Y2W AAYXX CITATION AIKXB EJD IPNFZ M48 NPM RIG SLJYH 7X8 5PM |
ID | FETCH-LOGICAL-c464t-d884a9b82526b97dd45c7574f69594abf859cc4d98d6f77bb6c572defb6892633 |
IEDL.DBID | DOA |
ISSN | 2391-5412 |
IngestDate | Wed Aug 27 01:31:43 EDT 2025 Thu Aug 21 18:26:42 EDT 2025 Thu May 15 20:01:06 EDT 2025 Fri May 16 02:48:47 EDT 2025 Sun Jul 06 05:08:16 EDT 2025 Thu Jul 10 10:34:17 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | platelet/lymphocyte ratio ulcerative colitis disease assessment neutrophil/lymphocyte ratio |
Language | English |
License | This work is licensed under the Creative Commons Attribution 4.0 International License. http://creativecommons.org/licenses/by/4.0 2025 the author(s), published by De Gruyter. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c464t-d884a9b82526b97dd45c7574f69594abf859cc4d98d6f77bb6c572defb6892633 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 These authors contributed equally to this study. |
OpenAccessLink | https://doaj.org/article/1f7cc0edf3c5426fadb0e7c9b51953c7 |
PMID | 40356724 |
PQID | 3203304999 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_1f7cc0edf3c5426fadb0e7c9b51953c7 pubmedcentral_primary_oai_pubmedcentral_nih_gov_12068185 proquest_miscellaneous_3203304999 pubmed_primary_40356724 crossref_primary_10_1515_biol_2025_1088 walterdegruyter_journals_10_1515_biol_2025_1088201 |
PublicationCentury | 2000 |
PublicationDate | 2025-05-05 |
PublicationDateYYYYMMDD | 2025-05-05 |
PublicationDate_xml | – month: 05 year: 2025 text: 2025-05-05 day: 05 |
PublicationDecade | 2020 |
PublicationPlace | Poland |
PublicationPlace_xml | – name: Poland |
PublicationTitle | Open life sciences |
PublicationTitleAlternate | Open Life Sci |
PublicationYear | 2025 |
Publisher | De Gruyter |
Publisher_xml | – name: De Gruyter |
References | 2025052707380701415_j_biol-2025-1088_ref_003 2025052707380701415_j_biol-2025-1088_ref_025 2025052707380701415_j_biol-2025-1088_ref_002 2025052707380701415_j_biol-2025-1088_ref_024 2025052707380701415_j_biol-2025-1088_ref_005 2025052707380701415_j_biol-2025-1088_ref_004 2025052707380701415_j_biol-2025-1088_ref_021 2025052707380701415_j_biol-2025-1088_ref_020 2025052707380701415_j_biol-2025-1088_ref_001 2025052707380701415_j_biol-2025-1088_ref_023 2025052707380701415_j_biol-2025-1088_ref_022 2025052707380701415_j_biol-2025-1088_ref_007 2025052707380701415_j_biol-2025-1088_ref_006 2025052707380701415_j_biol-2025-1088_ref_009 2025052707380701415_j_biol-2025-1088_ref_008 2025052707380701415_j_biol-2025-1088_ref_014 2025052707380701415_j_biol-2025-1088_ref_013 2025052707380701415_j_biol-2025-1088_ref_016 2025052707380701415_j_biol-2025-1088_ref_015 2025052707380701415_j_biol-2025-1088_ref_010 2025052707380701415_j_biol-2025-1088_ref_012 2025052707380701415_j_biol-2025-1088_ref_011 2025052707380701415_j_biol-2025-1088_ref_018 2025052707380701415_j_biol-2025-1088_ref_017 2025052707380701415_j_biol-2025-1088_ref_019 |
References_xml | – ident: 2025052707380701415_j_biol-2025-1088_ref_013 doi: 10.1136/gut.2005.082909 – ident: 2025052707380701415_j_biol-2025-1088_ref_006 doi: 10.1080/07853890.2024.2398725 – ident: 2025052707380701415_j_biol-2025-1088_ref_009 doi: 10.3390/nu13082583 – ident: 2025052707380701415_j_biol-2025-1088_ref_014 – ident: 2025052707380701415_j_biol-2025-1088_ref_018 doi: 10.1016/j.intimp.2021.108235 – ident: 2025052707380701415_j_biol-2025-1088_ref_002 doi: 10.1016/S0140-6736(17)32448-0 – ident: 2025052707380701415_j_biol-2025-1088_ref_012 doi: 10.1053/j.gastro.2006.12.038 – ident: 2025052707380701415_j_biol-2025-1088_ref_021 doi: 10.1089/ars.2012.4530 – ident: 2025052707380701415_j_biol-2025-1088_ref_011 doi: 10.1053/j.gastro.2016.02.032 – ident: 2025052707380701415_j_biol-2025-1088_ref_024 doi: 10.1152/ajpgi.00455.2015 – ident: 2025052707380701415_j_biol-2025-1088_ref_001 doi: 10.1097/CM9.0000000000003221 – ident: 2025052707380701415_j_biol-2025-1088_ref_017 doi: 10.5217/ir.2019.09156 – ident: 2025052707380701415_j_biol-2025-1088_ref_015 doi: 10.1016/B978-0-12-824472-2.00011-7 – ident: 2025052707380701415_j_biol-2025-1088_ref_005 doi: 10.1097/MS9.0000000000001297 – ident: 2025052707380701415_j_biol-2025-1088_ref_022 doi: 10.5009/gnl17216 – ident: 2025052707380701415_j_biol-2025-1088_ref_007 doi: 10.3390/cancers16162911 – ident: 2025052707380701415_j_biol-2025-1088_ref_020 doi: 10.3390/jcm5120118 – ident: 2025052707380701415_j_biol-2025-1088_ref_003 doi: 10.2478/fzm-2024-0003 – ident: 2025052707380701415_j_biol-2025-1088_ref_016 doi: 10.1515/jomb-2017-0050 – ident: 2025052707380701415_j_biol-2025-1088_ref_023 doi: 10.1016/j.molmed.2008.09.006 – ident: 2025052707380701415_j_biol-2025-1088_ref_019 doi: 10.1093/ecco-jcc/jjy215 – ident: 2025052707380701415_j_biol-2025-1088_ref_004 doi: 10.3390/ijms25137062 – ident: 2025052707380701415_j_biol-2025-1088_ref_008 doi: 10.1186/s43046-024-00208-4 – ident: 2025052707380701415_j_biol-2025-1088_ref_025 – ident: 2025052707380701415_j_biol-2025-1088_ref_010 doi: 10.1038/ajg.2015.6 |
SSID | ssj0001542506 |
Score | 2.343359 |
Snippet | This study aimed to investigate the clinical relevance of inflammatory markers in the severity assessment of ulcerative colitis (UC). The inflammatory markers... |
SourceID | doaj pubmedcentral proquest pubmed crossref walterdegruyter |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 20251088 |
SubjectTerms | disease assessment neutrophil/lymphocyte ratio platelet/lymphocyte ratio ulcerative colitis |
Title | Clinical relevance of inflammatory markers in the evaluation of severity of ulcerative colitis: A retrospective study |
URI | https://www.degruyter.com/doi/10.1515/biol-2025-1088 https://www.ncbi.nlm.nih.gov/pubmed/40356724 https://www.proquest.com/docview/3203304999 https://pubmed.ncbi.nlm.nih.gov/PMC12068185 https://doaj.org/article/1f7cc0edf3c5426fadb0e7c9b51953c7 |
Volume | 20 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlUOgltOnLbRNUKPRk4tVbvaUlIRTaUwO5CT3bQuINuzYl_74zsjfJ9kEvvRlZ2JJm5PnkmfmGkDdgk2PMnrU2i9yKwGzrdbDtwosA8CMXzjAb-dNndXomPp7L8zulvjAmbKIHnhbucFF0jF1OhUcJ1qT4FLqsow1Ii8JjzSMHm3fnMDXlB4MudmpmaQSbfYicRqASDHk3a5mVWytUyfr_hDB_D5Tc_VGd2Cl_XY3Xw8ZpWm3RyUOyO4NIejQN_hG5l_s9cn8qK3n9mIwz2ecFxYoo1cdPl4WCLoH4L6tbnV5iWM5qDY0UICC9Jf3GnmAtMxa1w-vxIuaJHZzGGiu3fkeP4MHDarnJ0qSVo_YJOTs5_vLhtJ3LK7RRKDG0yRjhbYAjIlPB6pSEjFpqUZSVVvhQjLQximRNUkXrEFSUmqVcgjKWKc6fkp1-2efnhAZjysKokLOXgnvtuUhayRx0BHgRbEPebpbbXU0sGg5PHyAYh4JxKBjkKjUNeY_SuOmF7Ne1AXTCzTrh_qUTDXm9kaWD3YIuEN_n5bh2nHX4AwdQcUOeTbK9eZXouFSaiYaYLalvjWX7Tv_9W2XkXrBOIfJpCPtFQdz8SVj_Zb6Av178jym_JA-qcmMopnxFdobVmPcBLg3hoO6Mn2W0GRc |
linkProvider | Directory of Open Access Journals |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZgKwSXijfhaSQkTlGzjp_cFkRZoC0HWqm3KH61SLsJyiZC_ffMJNltl8KFW5TYiZNvnPlsj78h5A34ZOdCyVITeEi5ZSYtlTXptOQW6EeIOcPdyIdHcn7Cv5yK0yt7YTCs0oezprtoB4XUPV-7DifKNloD4IH3UKEIAGaooglDuPN2ubhJdiSwfz0hO7P5p-_fLmdaBNhlJkfFxuu1tzxSL9z_N7Z5PWhy91e_oL1p7RW_tH-X7I6Eks4GC7hHboTqPrk1pJi8eEC6UfhzQTE7Sr_eT-tIwa7AFJb9EjtdYohOs4KTFOggvRQAx5LgOQMmuMPjbuHCoBROXR83t3pHZ3DjtqnXOzZpr1f7kJzsfzz-ME_HVAup45K3qdeal8bCcJFJa5T3XDglFI_SCMNLG7UwznFvtJdRKWulE4r5EK3Uhsk8f0QmVV2FJ4RareNUSxtCKXheqjLnXkkRrHJANaxJyNv15y5-DooaBY5EAJgCgSkQGNQt1Ql5j2hsSqESdn-ibs6KsWMV06icy4KPuQOcZSy9zYJyxqJsTu5UQl6vsSyg5-BySFmFulsVOctwMgcYckIeD9huHsWzXEjFeEL0Fupbbdm-Uv0479W5pyyTyIISwv4wkGL8Paz-8b7AxZ7-T6VX5Pb8-PCgOPh89PUZudMbNoZkiudk0jZdeAG0qbUvx37xG_MSGsE |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jb9QwFH6CqUBcKtYSViMhcYqa8W5uwzIMW0GCStwirwWpTaosQv332ElmylC4cIsSO3HyPed9tp-_B_A0-mRrvca58tTn1GCVa2FUPtfURPrhA8FpN_LHA746pO--sXU0YTuFVTp_1PRn3aiQuu9q26eJso3WQPTA-0mhKAKMk4pmHMKdunAZdjhXhM5gZ7F68-XT-UQLi2ZZ8Emw8WLlLYc06Pb_jWxejJnc_TmsZ28a-5tbWl6H3YlPosVoADfgkq9uwpUxw-TZLegn3c9jlJKjDMv9qA4omlW0hJNhhR2dpAidpo0nUWSD6Fz_O5WMjtOn_HbpuD-2fhQKR3YIm2ufo0W8cdfU6w2baJCrvQ2Hy9dfX67yKdNCbimnXe6kpFqZOFrE3CjhHGVWMEEDV0xRbYJkylrqlHQ8CGEMt0xg54PhUmFOyB2YVXXl7wIyUoa55MZ7zSjRQhPqBGfeCBuZhlEZPFt_7vJ0FNQo00AkAlMmYMoETJItlRm8SGhsSiUh7OFE3RyVU78q50FYW3gXiI0486CdKbywyiTVHGJFBk_WWJax46TVEF35um9Lgos0lxMJcgZ7I7abR9GCMC4wzUBuob7Vlu0r1Y_vgzj3HBc8kaAM8B8GUk5_h_Yf7xup2L3_qfQYrn5-tSw_vD14fx-uDXadAjLZA5h1Te8fRtLUmUdTt_gFIkgZ5w |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical+relevance+of+inflammatory+markers+in+the+evaluation+of+severity+of+ulcerative+colitis%3A+A+retrospective+study&rft.jtitle=Open+life+sciences&rft.au=He%2C+Tao&rft.au=Song%2C+Lian-Qiang&rft.au=Weng%2C+Xiao-Yu&rft.au=Pan%2C+Peng&rft.date=2025-05-05&rft.issn=2391-5412&rft.eissn=2391-5412&rft.volume=20&rft.issue=1&rft.spage=20251088&rft_id=info:doi/10.1515%2Fbiol-2025-1088&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2391-5412&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2391-5412&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2391-5412&client=summon |